1Workman RJ,Vaughn WK,Stone WJ.Dexamethasune suppression testing in chronic renal failure:Pharmacokinetics of dexamethasone and demonstration of a normal hypothalamic-pituitary-adrenal ads[J].J Clin Endocriol Metab,1986,63:741.
2Rosman PM,Farag A,Peckham R,et al.Pituitary-adrenocortical function in chronic renal failure:blunted suppression and early escape of plasma cortisol levels after intravenous dexamethasone[JJ.J Clin Endocriol Metab,1982,54:528.
4Drexler H,Zeiher A M,Wollschlager H. Flow-dependent coronary artery dilatation in humans[J].{H}CIRCULATION,1989,(3):466-474.
5Sorenson K E,Celermajer D S,Spiegelhaler D J. Non-invasive measurement of human endothelium dependent arterial responses:accuracy and reproducibility[J].{H}British Heart Journal,1995,(3):247-253.
6Folkesson H G,Norlin A,Wang Y. Dexamethasone and thyroid hormone pretreatment upregulate alveolar epithelial fluid clearance in adult rats[J].J Appl Physiol(1985),2000,(2):416-424.
